These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Alter drug structure--avert induced lupus. González ER JAMA; 1981 Oct; 246(15):1634. PubMed ID: 6168781 [No Abstract] [Full Text] [Related]
4. Acetylprocainamide therapy in patients with previous procainamide-induced lupus syndrome. Kluger J; Drayer DE; Reidenberg MM; Lahita R Ann Intern Med; 1981 Jul; 95(1):18-23. PubMed ID: 6166229 [TBL] [Abstract][Full Text] [Related]
5. Remission of procainamide-induced lupus erythematosus with N-acetylprocainamide therapy. Stec GP; Lertora JJ; Atkinson AJ; Nevin MJ; Kushner W; Jones C; Schmid FR; Askenazi J Ann Intern Med; 1979 May; 90(5):799-801. PubMed ID: 312047 [No Abstract] [Full Text] [Related]
6. Inhibition of Con A mitogenesis by serum from procainamide-treated patients and patients with systemic lupus erythematosus. Tannen RH; Cunningham-Rundles S Immunol Commun; 1982; 11(1):33-45. PubMed ID: 6178682 [TBL] [Abstract][Full Text] [Related]
7. Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide. Lahita R; Kluger J; Drayer DE; Koffler D; Reidenberg MM N Engl J Med; 1979 Dec; 301(25):1382-5. PubMed ID: 91972 [No Abstract] [Full Text] [Related]
8. Aromatic amines and the pathogenesis of lupus erythematosus. Reidenberg MM Am J Med; 1983 Dec; 75(6):1037-42. PubMed ID: 6196968 [TBL] [Abstract][Full Text] [Related]
9. The implications of procainamide metabolism to its induction of lupus. Uetrecht JP; Freeman RW; Woosley RL Arthritis Rheum; 1981 Aug; 24(8):994-1003. PubMed ID: 6169352 [TBL] [Abstract][Full Text] [Related]
10. Procainamide, NAPA and systemic lupus. Ahmad S Circulation; 1980 Apr; 61(4):865-6. PubMed ID: 6153583 [No Abstract] [Full Text] [Related]
11. A systemic lupus erythematosus-like syndrome induced by procainamide. Zeide MS; Wiesel S; Terry R; Stein D Clin Orthop Relat Res; 1978; (134):290-2. PubMed ID: 729256 [TBL] [Abstract][Full Text] [Related]
16. Efficacy, plasma concentrations and adverse effects of a new sustained release procainamide preparation. Giardina EG; Fenster PE; Bigger JT; Mayersohn M; Perrier D; Marcus FI Am J Cardiol; 1980 Nov; 46(5):855-62. PubMed ID: 6159783 [TBL] [Abstract][Full Text] [Related]
18. [Lupus erythematosus-like syndrome induced by long-term treatment with procainamide]. Wierzchowiecki M; Rybicka K Pol Arch Med Wewn; 1978 Feb; 59(2):197-201. PubMed ID: 758078 [No Abstract] [Full Text] [Related]
19. Lupus erythematosus cells in pleural effusion: the initial manifestation of procainamide-induced lupus erythematosus. Carel RS; Shapiro MS; Shoham D; Gutman A Chest; 1977 Nov; 72(5):670-2. PubMed ID: 71976 [TBL] [Abstract][Full Text] [Related]